Restore the Man | A men’s health resource for health professionals

Register

Upcoming Webinars

Upcoming Webinars

23

Sep

19:30 hrs

Testosterone Deficiency and Diabetes

15

Oct

19:30 hrs

Testosterone Deficiency and Diabetes: 4 x interactive case studies

Archived Webinars

Archived Webinars 2020

25

Mar

19:30 hrs

Basic Testosterone Deficiency

29

Apr

19:30 hrs

Basic Testosterone Deficiency: 4 x interactive case studies

20

May

19:30 hrs

Erectile Dysfunction and TD

24

Jun

19:30 hrs

Erectile Dysfunction and TD: 4 x interactive case studies

Archived Webinars 2019

26

Mar

19:00 hrs

An Overview of Testosterone Deficiency

9

Apr

19:00 hrs

Understanding Erectile Dysfunction

14

May

19:00 hrs

Screening for and Treating Testosterone Deficiency in Male Diabetic Patients

19

Jun

19:00 hrs

Female Menopause and Male Hypogonadism: What have we learned?

27

Jun

19:00 hrs

Cardiovascular Disease and Testosterone Deficiency: Unpacking the Evidence

10

Sep

19:00 hrs

Prostate Health and Testosterone Replacement Therapy (TRT): Clinical Considerations

10

Oct

19:00 hrs

Klinefelter Syndrome: Rare or Rarely Diagnosed?

19

Nov

19:00 hrs

Male Hypogonadism: A Neglected Diagnosis?

Regional Webinars

30

Sep

19:00 hrs

Erectile Dysfunction and Testosterone Deficiency

Resources

Clinical updates

Keep up-to-date with the guidelines on men's health.

Educational programme

CPD accredited online module to help you manage your male patients’ health.

Clinical tools

Useful testosterone tools for the evaluation and management of your male patients.

Register for Latest News

Join ~2,000 healthcare professionals and don’t miss out on the latest news.

REFERENCES

Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60: 762-769.

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido^® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.

Page last modified 08/06/2020

PP-NEB-GB-0300 June 2020

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.

If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

www.bssm.org.uk